Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Odontology ; 111(4): 993-1002, 2023 Oct.
Article in English | MEDLINE | ID: mdl-36853425

ABSTRACT

Alveolar ridge augmentation of atrophic posterior mandibular ridge represents a challenge in oral and maxillofacial surgery to restore aesthetic and function. The aim of the study was to compare the clinical and radiographic outcomes of bone formation in atrophic posterior mandibles augmented using onlay symphysis cortico-cancellous bone block with that augmented using sandwich bone augmentation technique (Inlay). Twelve patients were selected with missing mandibular posterior teeth. CBCT were done for all patients preoperatively to assess the residual bone height, ranged between 5 and 7 mm from the inferior alveolar nerve with adequate sufficient alveolar ridge width more than 4 mm. Patients required bone augmentation procedure with autologous onlay chin graft (group I) versus those used as inlay sandwich technique (group II). Clinical and radiographic analysis were done to analyses the newly formed bone and bone height. Percent of change in bone height was also calculated and revealed that group I was higher than group II, however, statistically insignificant differences between the two groups were found regarding the percentage of newly formed bone. Vertical ridge augmentation procedures using onlay chin graft took lesser time than the interpositional grafting with fixation technique, however, both techniques are promising for vertical ridge augmentation.


Subject(s)
Alveolar Ridge Augmentation , Inlays , Humans , Bone Transplantation/methods , Mandible/surgery , Dental Implantation, Endosseous , Chin/surgery , Alveolar Ridge Augmentation/methods
2.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-982011

ABSTRACT

In December 2022, the American Academy of Pediatrics released a clinical guideline for point-of-care ultrasonography (POCUS) in the neonatal intensive care unit (NICU). The guideline outlined the development and current status of POCUS in the NICU, and summarized the key elements and implementation guidelines for successful implementation of POCUS in the NICU. This article provides an overview of the key points of the clinical guideline and analyzes the current status of POCUS in China, providing a reference for the implementation of POCUS in neonatal care in China.


Subject(s)
Infant, Newborn , Humans , Child , United States , Intensive Care Units, Neonatal , Point-of-Care Systems , Ultrasonography , China
3.
Plast Reconstr Surg Glob Open ; 10(11): e4648, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36438472

ABSTRACT

Self-inflicted hand injuries have been described in the literature with varying nomenclature (factitious, malingering, and self-induced hand injuries). Identifying and treating these patients is complex and requires a multidisciplinary team approach at a high cost. There is a lack of literature that describes the different patterns and characteristics of hand injuries among military personnel, especially in Saudi Arabia. We conducted a chart review study involving military personnel who attended the emergency department with hand injuries in Saudi Arabia to fill this gap. Methods: This retrospective chart review study was conducted at a tertiary hospital in Riyadh, Saudi Arabia. Our inclusion criteria included military personnel patients who presented to the emergency department with intentional self-inflicted hand-related injuries between 2016 and 2018. Results: A total of 274 cases were included; 241 (88%) were men. Injuries to the left hand (52.2%) were more common than injuries to the right hand. The most common injury site involved the little finger (45.6%). The majority were followed up (97.8%), and 28.8% of cases had a complication. The majority of fractures were managed with open reduction and internal fixation (63.9%). Moreover, the mean sick leave duration was 23 days. Conclusions: Self-inflicted injuries can be challenging to diagnose when patients are manipulative about the cause and mechanism. Most self-inflicted injuries involved the left little finger, and most were treated with open reduction and internal fixation. A self-inflicted injury is possible in the context of an unusual injury with a vague medical history.

4.
Int Urol Nephrol ; 51(9): 1639-1647, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31363959

ABSTRACT

BACKGROUND AND AIMS: New direct-acting antiviral drugs have become the corner-stone treatment for HCV infection: they show promising results with accepted side-effects and low dropout rates. One of the available regimens is paritaprevir/ombitasvir/ritonavir (PTV/OMV/RTV). Our aim was to study the efficacy and safety of this drug regimen among HCV-positive hemodialysis patients. METHODS: This prospective single-center study was performed in the Urology and Nephrology Center, Mansoura University, Egypt. Ninety-six maintenance hemodialysis patients were screened for HCV antibodies. Positive results were found in 46 patients (47.9%). HCV PCR was assessed in all HCV-antibody-positive patients; positive results were found positive for 38 (82%); all patients were HCV genotype 4. Four patients were excluded due to advanced liver cirrhosis, liver malignancy, or metastatic breast cancer. Thirty-four patients were prescribed PTV/OMV/RTV for 3 months to treat HCV. RESULTS: Mean age was 43.2 ± 11.9 years. Most patients were male (67.6%). There was a rapid response to treatment: HCV PCR became negative by 4 weeks after starting treatment. By 12 and 24 weeks post-DAA therapy, there was a sustained viral response (SVR 12, SVR 24) in 100% of patients with improved liver-enzyme levels. CONCLUSION: The PTV/OMV/RTV regimen was safe and effectively treated Egyptian HCV-positive genotype-4 hemodialysis patients.


Subject(s)
Anilides/administration & dosage , Antiviral Agents/administration & dosage , Carbamates/administration & dosage , Cytochrome P-450 CYP3A Inhibitors/administration & dosage , Hepatitis C, Chronic/drug therapy , Macrocyclic Compounds/administration & dosage , Renal Dialysis , Ritonavir/administration & dosage , Adult , Anilides/adverse effects , Antiviral Agents/adverse effects , Carbamates/adverse effects , Cyclopropanes , Cytochrome P-450 CYP3A Inhibitors/adverse effects , Drug Combinations , Egypt , Female , Humans , Lactams, Macrocyclic , Macrocyclic Compounds/adverse effects , Male , Middle Aged , Proline/analogs & derivatives , Prospective Studies , Ritonavir/adverse effects , Sulfonamides , Treatment Outcome , Valine
5.
Exp Clin Transplant ; 17(1): 79-83, 2019 02.
Article in English | MEDLINE | ID: mdl-29957163

ABSTRACT

OBJECTIVES: Liver disease is an important cause of morbidity and mortality among recipients of transplanted organs. In addition to the liver, hepatitis C virus infection has a significant prevalence among recipients of kidney transplant and is related to worse graft and recipient survival as the kidney is an important component of the hepatitis C virus clinical syndrome. MATERIALS AND METHODS: This retrospective single center study included 336 patients with end-stage renal disease who received a kidney transplant at the Mansoura Urology and Nephrology Center from January 1992 to December 1995. Of 336 patients, 63 were excluded, and the remaining 273 patients were divided into 3 groups: viremic active (72 patients), viremic inactive (108 patients), and nonviremic (93 patients). Division of patients was based on hepatitis C virus RNA complement level (C3 and/or C4 consumption), circulating cryoglobulins, and rheumatoid factor detection. RESULTS: Our study showed insignificant differences regarding patient characteristics and demographic data among the study groups but significantly higher incidence of transaminitis in viremic (active and inactive) patients. Nonsignificant differences were found regarding proteinuria among the 3 groups, including among those who had levels in either nephrotic or nonnephrotic ranges. Biopsy-proven acute rejection episodes among the 3 groups of recipients were statistically comparable, with significantly higher frequency of chronic rejection episodes among viremic active patients. Nonviremic recipients had significantly lower serum creatinine levels than viremic (active and inactive) recipients. Patient and graft survival results were comparable among the groups. CONCLUSIONS: Presence of hepatitis C virus immunologic markers does not have a significant effect on patient and graft survival; however, it may be a clue for long-term incidence of chronic rejection.


Subject(s)
Complement C3/analysis , Complement C4/analysis , Cryoglobulins/analysis , Hepacivirus/immunology , Hepatitis C/immunology , Kidney Failure, Chronic/surgery , Kidney Transplantation/methods , Living Donors , Rheumatoid Factor/blood , Adolescent , Adult , Biomarkers/blood , Child , Egypt/epidemiology , Female , Graft Rejection/immunology , Graft Rejection/mortality , Graft Survival , Hepacivirus/genetics , Hepatitis C/blood , Hepatitis C/mortality , Hepatitis C/virology , Humans , Incidence , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/immunology , Kidney Failure, Chronic/mortality , Kidney Transplantation/adverse effects , Kidney Transplantation/mortality , Male , Middle Aged , RNA, Viral/blood , RNA, Viral/genetics , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome , Young Adult
6.
Exp Clin Transplant ; 16(2): 133-137, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28760116

ABSTRACT

OBJECTIVES: Renal transplant is the criterion standard for treatment of end-stage renal disease. The effects of disparities between men and women on renal transplant outcomes have been evaluated in many studies but with debatable results. It has been suggested that female kidney donors have poor outcomes after transplant compared with male kidney donors, especially when implanted in a male recipient. The aim of the study was to evaluate the effects of sex on living-donor kidney transplant outcome. MATERIALS AND METHODS: The data of 979 patients who underwent living-donor kidney transplant from January 2000 to December 2010 at a single center were reviewed retrospectively. The patients were divided into 4 groups according to recipient and donor sex: male donor-to-male recipient (n = 307), male donor-to-female recipient (n = 132), female donor-to-male recipient (n = 411), and female donor-to-female recipient (n = 129). We compared the demographic characteristics, posttransplant rejection and complications, and graft and patient survival rates among the groups. RESULTS: Male recipients were older than female recipients, whereas male donors were younger than female donors (P < .001). No statistically significant differences were shown regarding recipient body mass index, ischemia time and time to diuresis, and acute and chronic rejection rates between the groups. Graft (P = .947) and patient (P = .421) survival rates were comparable between groups. CONCLUSIONS: Donor and recipient sex had no significant effect on outcomes of living-donor renal allograft recipients.


Subject(s)
Kidney Transplantation/methods , Living Donors , Adolescent , Adult , Age Factors , Allografts , Egypt , Female , Graft Rejection/etiology , Graft Rejection/mortality , Graft Survival , Humans , Kidney Transplantation/adverse effects , Kidney Transplantation/mortality , Male , Retrospective Studies , Risk Factors , Sex Factors , Time Factors , Treatment Outcome , Young Adult
7.
Nephrourol Mon ; 8(3): e34770, 2016 May.
Article in English | MEDLINE | ID: mdl-27570751

ABSTRACT

BACKGROUND: Renal transplantation is the ideal method for management of end-stage renal disease. The use of living donors for renal transplantation was critical for early development in the field and preceded the use of cadaveric donors. Most donors are related genetically to the recipients, like a parent, a child, or a sibling of the recipient, but there are an increasing percentage of cases where donors are genetically unrelated like spouses, friends, or altruistic individuals. Donor shortages constitute the major barrier for kidney transplantation, and much effort has been made to increase the supply of living donors. The impact of donor source on the outcome of renal transplantation is not adequately studied in our country. OBJECTIVES: The aim of the study was to evaluate the impact of donor source on the outcome of live donor kidney transplantation. PATIENTS AND METHODS: From March 1976 to December 2013, the number of patients that underwent living renal transplantation sharing at least one HLA haplotype with their donors was 2,485. We divided these patients into two groups: (1) 2,075 kidney transplant recipients (1,554 or 74.9% male and 521 or 25.1% female) for whom the donors were living related, (2) 410 kidney transplant recipients (297 or 72.4% male and 113 or 27.6% female) for whom the donors were living unrelated. All patients received immunosuppressive therapy, consisting of a calcineurin inhibitor, mycophenolate mofetil, or azathioprine and prednisolone. We compared acute rejection and complication rates, as well as long-term graft and patient survival of both groups. Demographic characteristics were compared using the chi-square test. Graft survival and patient survival were calculated using the Kaplan-Meier method. RESULTS: The percentages of patients with acute vascular rejection were significantly higher in the unrelated group, while percentages of patients with no rejection were significantly higher in the related group, but there were no significant differences regarding patient and graft survivals between both groups. CONCLUSIONS: Kidney transplant recipients who received their grafts either from live related donors or live unrelated donors had comparable patient and graft survival outcomes.

8.
Electron Physician ; 8(2): 2030-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-27054015

ABSTRACT

INTRODUCTION: Cardiomyopathy may cause disruptions in the micro-vascular system of the stria vascularis in the cochlea, and, subsequently, may result in cochlear degeneration. Degeneration in the stria vascularis affects the physical and chemical processes in the organ of Corti, thereby causing a possible hearing impairment. The objective of this study was to assess the hearing profiles of patients with dilated and hypertrophic cardiomyopathies to determine the relationship between the degree of hearing loss and the degree and duration of the disease and to compare the dilated and hypertrophic cardiomyopathies as regards hearing profile. METHODS: In this case control study, we studied 21 patients (cases/study group/group 1) and 15 healthy individuals (controls/group 2). Six patients (group 1a) had hypertrophic cardiomyopathy (HCM), and 15 patients (group 1b) had dilated cardiomyopathy (DCM). The data were analyzed using the t-test, chi-squared test, Kruskal-Wallis test, and the Multiple Mann-Whitney test. RESULTS: The results of this study showed that 80% of those patients with DCM (group 1b) had bilateral sensorineural hearing loss (SNHL), and 100% of the patients with HCM (group 1a) had mild to severe bilateral sloping SNHL. Distortion Product Otoacoustic Emissions (DPOAEs) were present in 14% of the study group and in 100 % of the control group. The results of the measurements of auditory brainstem response (ABR) showed that 50% of the study group had abnormal latencies compared to the control group, and there was no correlation between the duration of the disease and the degree of hearing loss or DPOAE. Fifty percent of the patients with HCM and 35% of the patients with DCM had positive family histories of similar conditions, and 35% of those with HCM had a positive family history of sudden death. CONCLUSION: The results of this study suggested that the link between heart disease and hearing loss and early identification of hearing loss in patients with cardiomyopathy may reduce morbidity since hearing deficits sometimes precede heart disease.

9.
Saudi J Kidney Dis Transpl ; 21(3): 511-4, 2010 May.
Article in English | MEDLINE | ID: mdl-20427879

ABSTRACT

Infants born to mothers with deficiency of vitamin D and/or calcium due to cultural modifications in their diets, life style and clothing habits, are at risk of developing early and fatal sequelae of hypocalcemic vitamin D deficiency. We present a 44-day-old infant with hypocalcemia secondary to congenital vitamin D deficiency, who presented as a recurrent Acute Life Threatening Event (ALTE) resulting in an unexpectedly prolonged intensive care course. This report suggests that evaluation of vitamin D status should be included as part of the workup of ALTE and we describe evidence-based preventive measures for both mothers and infants who are at risk for vitamin D deficiency.


Subject(s)
Hypocalcemia/etiology , Infant Nutritional Physiological Phenomena , Maternal Nutritional Physiological Phenomena , Vitamin D Deficiency/congenital , Acute Disease , Biomarkers/blood , Calcifediol/administration & dosage , Calcifediol/blood , Calcium/administration & dosage , Calcium/blood , Critical Care , Dietary Supplements , Female , Humans , Hypocalcemia/blood , Hypocalcemia/physiopathology , Hypocalcemia/therapy , Infant , Intensive Care Units, Pediatric , Length of Stay , Male , Pregnancy , Recurrence , Risk Factors , Time Factors , Treatment Outcome , Vitamin D Deficiency/blood , Vitamin D Deficiency/physiopathology , Vitamin D Deficiency/therapy , Vitamins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...